{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T17:21:23Z","timestamp":1786123283753,"version":"build-2736575974"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1213\/ane.0b013e318232053e","type":"journal-article","created":{"date-parts":[[2011,10,4]],"date-time":"2011-10-04T18:46:18Z","timestamp":1317753978000},"page":"1461-1467","source":"Crossref","is-referenced-by-count":16,"title":["Mutated p.4894 RyR1 Function Related to Malignant Hyperthermia and Congenital Neuromuscular Disease with Uniform Type 1 Fiber (CNMDU1)"],"prefix":"10.1213","volume":"113","author":[{"given":"Toshiaki","family":"Haraki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshimichi","family":"Yasuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiko","family":"Mukaida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takako","family":"Migita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Hamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Kawamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-27-20210902","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/0888-7543(91)90084-R","article-title":"A substitution of cysteine for arginine 614 in the ryanodine receptor is potentially causative of human malignant hyperthermia.","volume":"11","author":"Gillard","year":"1991","journal-title":"Genomics"},{"key":"R2-27-20210902","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1097\/00000542-200606000-00008","article-title":"Malignant hyperthermia in Japan: mutation screening of the entire ryanodine receptor type 1 gene coding region by direct sequencing.","volume":"104","author":"Ibarra","year":"2006","journal-title":"Anesthesiology"},{"key":"R3-27-20210902","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.ceca.2005.06.037","article-title":"Ryanodine receptors.","volume":"38","author":"Hamilton","year":"2005","journal-title":"Cell Calcium"},{"key":"R4-27-20210902","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.2217\/14622416.9.11.1657","article-title":"Malignant hyperthermia: a pharmacogenetic disorder.","volume":"9","author":"Stowell","year":"2008","journal-title":"Pharmacogenomics"},{"key":"R5-27-20210902","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/humu.20356","article-title":"Mutations in RYR1 in malignant hyperthermia and central core disease.","volume":"27","author":"Robinson","year":"2006","journal-title":"Hum Mutat"},{"key":"R6-27-20210902","doi-asserted-by":"crossref","first-page":"a003996","DOI":"10.1101\/cshperspect.a003996","article-title":"Ryanodine receptors: structure, expression, molecular details, and function in calcium release.","volume":"2","author":"Lanner","year":"2010","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"R7-27-20210902","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1213\/ANE.0b013e3181cbd815","article-title":"Functional properties of RYR1 mutations identified in Swedish patients with malignant hyperthermia and central core disease.","volume":"111","author":"Vukcevic","year":"2010","journal-title":"Anesth Analg"},{"key":"R8-27-20210902","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1002\/(SICI)1098-1004(200005)15:5<410::AID-HUMU2>3.0.CO;2-D","article-title":"Ryanodine receptor mutations in malignant hyperthermia and central core disease.","volume":"15","author":"McCarthy","year":"2000","journal-title":"Hum Mutat"},{"key":"R9-27-20210902","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1002\/humu.9442","article-title":"Frequency and localization of mutations in the 106 exons of the RYR1 gene in 50 individuals with malignant hyperthermia.","volume":"27","author":"Galli","year":"2006","journal-title":"Hum Mutat"},{"key":"R10-27-20210902","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1097\/00000542-200503000-00007","article-title":"Screening of the entire ryanodine receptor type 1 coding region for sequence variants associated with malignant hyperthermia susceptibility in the North American population.","volume":"102","author":"Sambuughin","year":"2005","journal-title":"Anesthesiology"},{"key":"R11-27-20210902","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1002\/humu.20878","article-title":"Increasing the number of diagnostic mutations in malignant hyperthermia.","volume":"30","author":"Levano","year":"2009","journal-title":"Hum Mutat"},{"key":"R12-27-20210902","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/ng0993-51","article-title":"Mutations in the ryanodine receptor gene in central core disease and malignant hyperthermia.","volume":"5","author":"Quane","year":"1993","journal-title":"Nat Genet"},{"key":"R13-27-20210902","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/ng0993-46","article-title":"A mutation in the human ryanodine receptor gene associated with central core disease.","volume":"5","author":"Zhang","year":"1993","journal-title":"Nat Genet"},{"key":"R14-27-20210902","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/humu.20231","article-title":"Correlations between genotype and pharmacological, histological, functional, and clinical phenotypes in malignant hyperthermia susceptibility.","volume":"26","author":"Monnier","year":"2005","journal-title":"Hum Mutat"},{"key":"R15-27-20210902","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1001\/archneur.1983.04050030041007","article-title":"Nonprogressive congenital neuromuscular disease with uniform type 1 fiber.","volume":"40","author":"Oh","year":"1983","journal-title":"Arch Neurol"},{"key":"R16-27-20210902","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1212\/01.wnl.0000269792.63927.86","article-title":"Congenital neuromuscular disease with uniform type 1 fiber and RYR1 mutation.","volume":"70","author":"Sato","year":"2008","journal-title":"Neurology"},{"key":"R17-27-20210902","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S0387-7604(00)00108-X","article-title":"Central core disease and congenital neuromuscular disease with uniform type 1 fibers in one family.","volume":"22","author":"Tojo","year":"2000","journal-title":"Brain Dev"},{"key":"R18-27-20210902","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s00540-009-0746-3","article-title":"Functional analysis of ryanodine receptor type 1 p.R2508C mutation in exon 47.","volume":"23","author":"Migita","year":"2009","journal-title":"J Anesth"},{"key":"R19-27-20210902","doi-asserted-by":"crossref","first-page":"26332","DOI":"10.1074\/jbc.272.42.26332","article-title":"Caffeine and halothane sensitivity of intracellular Ca2 release is altered by 15 calcium release channel (ryanodine receptor) mutations associated with malignant hyperthermia andor central core disease.","volume":"272","author":"Tong","year":"1997","journal-title":"J Biol Chem"},{"key":"R20-27-20210902","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1016\/S0006-3495(97)78221-3","article-title":"Single-channel properties of the recombinant skeletal muscle Ca2 release channel (ryanodine receptor).","volume":"73","author":"Chen","year":"1997","journal-title":"Biophys J"},{"key":"R21-27-20210902","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/j.1365-2044.2004.03658.x","article-title":"Dantrolene: a review of its pharmacology, therapeutic use and new developments.","volume":"59","author":"Krause","year":"2004","journal-title":"Anaesthesia"},{"key":"R22-27-20210902","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0165-6147(98)01184-5","article-title":"A tool coming of age: thapsigargin as an inhibitor of sarco-endoplasmic reticulum Ca(2)-ATPases.","volume":"19","author":"Treiman","year":"1998","journal-title":"Trends Pharmacol Sci"},{"key":"R23-27-20210902","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1074\/jbc.274.2.693","article-title":"Measurement of resting cytosolic Ca2 concentrations and Ca2 store size in HEK-293 cells transfected with malignant hyperthermia or central core disease mutant Ca2 release channels.","volume":"274","author":"Tong","year":"1999","journal-title":"J Biol Chem"},{"key":"R24-27-20210902","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/228034a0","article-title":"Calcium induced release of calcium from the sarcoplasmic reticulum of skinned skeletal muscle fibres.","volume":"228","author":"Endo","year":"1970","journal-title":"Nature"},{"key":"R25-27-20210902","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1152\/physrev.00040.2008","article-title":"Calcium-induced calcium release in skeletal muscle.","volume":"89","author":"Endo","year":"2009","journal-title":"Physiol Rev"},{"key":"R26-27-20210902","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s005400050002","article-title":"Comparison of the in vitro caffeine-halothane contracture test with the Ca-induced Ca release rate test in patients suspected of having malignant hyperthermia susceptibility.","volume":"14","author":"Oku","year":"2000","journal-title":"J Anesth"},{"key":"R27-27-20210902","doi-asserted-by":"crossref","first-page":"4164","DOI":"10.1073\/pnas.96.7.4164","article-title":"A mutation in the transmembraneluminal domain of the ryanodine receptor is associated with abnormal Ca2 release channel function and severe central core disease.","volume":"96","author":"Lynch","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"R28-27-20210902","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1085\/jgp.118.3.277","article-title":"Functional effects of central core disease mutations in the cytoplasmic region of the skeletal muscle ryanodine receptor.","volume":"118","author":"Avila","year":"2001","journal-title":"J Gen Physiol"},{"key":"R30-27-20210902","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1085\/jgp.200308791","article-title":"The pore region of the skeletal muscle ryanodine receptor is a primary locus for excitation-contraction uncoupling in central core disease.","volume":"121","author":"Avila","year":"2003","journal-title":"J Gen Physiol"},{"key":"R31-27-20210902","doi-asserted-by":"crossref","first-page":"e1000367","DOI":"10.1371\/journal.pcbi.1000367","article-title":"A structural model of the pore-forming region of the skeletal muscle ryanodine receptor (RyR1).","volume":"5","author":"Ramachandran","year":"2009","journal-title":"PLoS Comput Biol"},{"key":"R32-27-20210902","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/S0006-3495(00)76339-9","article-title":"Evidence for a role of the lumenal M3-M4 loop in skeletal muscle Ca(2) release channel (ryanodine receptor) activity and conductance.","volume":"79","author":"Gao","year":"2000","journal-title":"Biophys J"},{"key":"R33-27-20210902","doi-asserted-by":"crossref","first-page":"25971","DOI":"10.1074\/jbc.274.37.25971","article-title":"Molecular identification of the ryanodine receptor pore-forming segment.","volume":"274","author":"Zhao","year":"1999","journal-title":"J Biol Chem"},{"key":"R34-27-20210902","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.coph.2008.01.005","article-title":"Congenital muscle disorders with cores: the ryanodine receptor calcium channel paradigm.","volume":"8","author":"Treves","year":"2008","journal-title":"Curr Opin Pharmacol"},{"key":"R35-27-20210902","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1093\/hmg\/10.25.2879","article-title":"Identification of four novel mutations in the C-terminal membrane spanning domain of the ryanodine receptor 1: association with central core disease and alteration of calcium homeostasis.","volume":"10","author":"Tilgen","year":"2001","journal-title":"Hum Mol Genet"},{"key":"R36-27-20210902","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0960-8966(02)00218-3","article-title":"Principal mutation hotspot for central core disease and related myopathies in the C-terminal transmembrane region of the RYR1 gene.","volume":"13","author":"Davis","year":"2003","journal-title":"Neuromuscul Disord"},{"key":"R37-27-20210902","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1136\/jmg.2003.014274","article-title":"RYR1 mutations in UK central core disease patients: more than just the C-terminal transmembrane region of the RYR1 gene.","volume":"41","author":"Shepherd","year":"2004","journal-title":"J Med Genet"},{"key":"R38-27-20210902","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0143-4160(03)00050-2","article-title":"Retrograde activation of store-operated calcium channel.","volume":"33","author":"Ma","year":"2003","journal-title":"Cell Calcium"},{"key":"R39-27-20210902","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1152\/physrev.00057.2003","article-title":"Store-operated calcium channels.","volume":"85","author":"Parekh","year":"2005","journal-title":"Physiol Rev"},{"key":"R40-27-20210902","doi-asserted-by":"crossref","first-page":"33477","DOI":"10.1074\/jbc.M602306200","article-title":"Azumolene inhibits a component of store-operated calcium entry coupled to the skeletal muscle ryanodine receptor.","volume":"281","author":"Zhao","year":"2006","journal-title":"J Biol Chem"}],"container-title":["Anesthesia &amp; Analgesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1213\/ANE.0b013e318232053e","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:17:23Z","timestamp":1786112243000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000539-201112000-00027"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1213\/ane.0b013e318232053e","relation":{},"ISSN":["0003-2999"],"issn-type":[{"value":"0003-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}